Latest Hardware News

RocketDNA’s unaudited Q3 FY26 revenue rose 31% year-on-year to A$2.46 million, while xBot recurring revenue exceeded half of group revenue for the first time. The shift comes alongside expanding deployments, a A$2.23 million placement and continued cash investment in the platform.

Elsight delivered US$25.8 million in unaudited revenue for the first nine months of 2026, up 91% on the prior corresponding period, but a weaker-than-expected third quarter produced a non-GAAP loss. The company is relying on expanded US defence procurement access, new products and a US$196 million opportunity pipeline to support future growth.

Resonance Health has reported encouraging preliminary results from an investigational MRI software device that identifies liver fibrosis without additional scanner hardware. The early data are promising, but the model remains unverified and regulatory clearance is still ahead.

Data#3 has upgraded its FY27 first-half profit projection after delivering record FY26 sales, earnings and dividends. The company expects strong early-year growth, although one-off transactions and a softer second-half growth rate will shape the full-year result.

Ocean Sciences has committed A$100,000 to a 12-month research program testing whether Sargassum-derived alginate can recover gold, silver and potentially rare earth elements from retired data centre hardware. The project gives the seaweed company a new industrial angle, but remains firmly at the laboratory stage.

RooLife Group opened FY2027 with A$7.9 million in unaudited revenue and customer cash receipts up 884% year on year. The stronger quarter comes as its Aurora renewable energy division shifts from acquisition and product development towards project execution, although operating cash flow remains negative.

Archer Materials has moved its IonQ relationship into early commercial activity and advanced its Biochip towards external testing, but its graphene spin qubit demonstration is taking longer than expected. The company ended September with $A13.0 million in cash and an estimated 4.68 quarters of funding at its quarterly operating burn.

Audeara has moved two AI noise reduction licensing programs into commercial production, helping lift quarterly revenue 37.7% while initial orders remain modest. The milestone arrives alongside A$247,000 in cash, a A$1.292 million operating outflow and a pending A$505,000 placement tranche.

Lumos Diagnostics has expanded FebriDx deployment to 265 US healthcare sites across 29 states, while product revenue rose 224% in the first quarter. The commercial gains came alongside a US$4.7 million operating cash outflow, slower-than-planned paediatric study enrolment and a Hologic development timeline pushed to around June 2028.

SCX.ai has reported positive operating cash flow in its first quarter as an ASX-listed company, alongside a 54% increase in annualised recurring revenue since its prospectus. The sovereign AI infrastructure provider also has more than 100 commercial customers and $23.9 million in cash, but its next test is converting new capacity and partnerships into durable revenue.

Beam Communications delivered positive operating cashflow of $160,000 in Q1FY27 despite a much smaller post-Zoleo revenue base, while core hardware sales lifted quarterly revenue by 20.2%. The company expects positive operating cashflow to continue through FY27, but recurring revenue and SatPhone Shop sales weakened.

GenusPlus has won approximately $255 million of power infrastructure work from Western Power and Fortescue, extending its project pipeline into 2029. The awards span renewable energy connections, network maintenance and mine-site decarbonisation infrastructure, although individual contract values and margins remain undisclosed.